Haleon (LON:HLN) Hits New 12-Month High – Here’s What Happened

Haleon plc (LON:HLN)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as GBX 715.10 ($8.93) and last traded at GBX 370.80 ($4.63), with a volume of 56901801 shares changing hands. The stock had previously closed at GBX 371.40 ($4.64).

Haleon Price Performance

The stock has a market capitalization of £33.59 billion, a PE ratio of 3,096.67, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The business’s 50-day moving average price is GBX 375.68 and its 200 day moving average price is GBX 372.52. The company has a debt-to-equity ratio of 54.18, a quick ratio of 0.93 and a current ratio of 0.84.

Insider Buying and Selling

In other Haleon news, insider Dawn Allen sold 74,679 shares of Haleon stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of GBX 372 ($4.64), for a total transaction of £277,805.88 ($346,867.12). Also, insider Alan Stewart purchased 33,923 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was bought at an average cost of GBX 368 ($4.59) per share, for a total transaction of £124,836.64 ($155,870.45). 10.74% of the stock is owned by company insiders.

Haleon Company Profile

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.